Therapeutic Apheresis in Clinical Practice, ASFA,
Kidney Health Guidance for CKM Syndrome, ASN,
2026 ESC Guidelines for Cardiovascular Disease and CKD, ESC/ERA,
Pediatric Urinary Tract Infection: Diagnosis and Stewardship, CPS,
Laboratory Diagnosis and Monitoring of Thrombotic Thrombocytopenic Purpura, BSH,
Management of Heart Failure With Preserved Ejection Fraction, ACC,
Diagnosis of Light Chain Amyloidosis, ASH,
Prevention of Invasive Aspergillosis After Solid Organ Transplantation, IDSA,
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus, BSR (UKKA-endorsed),
2026 Guideline for Cardiovascular-Kidney-Metabolic Syndrome, AHA/ACC/ADA/ASN,
Using Predicted Risk and Expected Benefit in CKM Syndrome, AHA/ACC,
U.S. Pharmacy Organizations Endorse Transition from Cockcroft-Gault Estimated Creatinine Clearance to the 2021 CKD-EPI Equation for Estimated Glomerular Filtration Rate to Improve Medication-related Decision-making in Adults Across Healthcare Settings, NKF/US pharmacy organizations,
The Kidney in Cardiovascular-Kidney-Metabolic Syndrome, KDIGO,
Early Diagnosis of Light Chain Amyloidosis, BSH,
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV), NKF/KDOQI,
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD, NKF/KDOQI,
KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney, ERA,
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, KDIGO,
Complement inhibitors and B cell–modifying agents for IgA nephropathy—a Kidney Disease: Improving Global Outcomes (KDIGO) commentary, KDIGO,
ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure, ASN,
Management of Type 2 Diabetes: 2026 Algorithm Update, AACE,
Kidney Disease and Heart Failure: Advances and Challenges, KDIGO,
Bone Turnover Markers in CKD-Associated Osteoporosis, ERA/IOF/EFLM/ESPN,
Green dialysis: environmentally sustainable care, growth, and innovation: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, KDIGO,
Management of antithrombotic therapies in kidney transplantation candidates and recipients: an ERBP clinical practice document by the DESCaRTES Working Group of ERA and the EKITA Committee of ESOT, ERA/ERBP/ESOT,
KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP), ERA/ERBP,
ERA’s ABCDE framework for kidney disease prevention: turning the WHO kidney health resolution into action, ERA,
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD), KDIGO,
Management of Lupus Nephritis, EULAR,
Fluid Therapy in Critically Ill Adults, Part 3: Fluid Removal, ESICM,
Management of ANCA-Associated Vasculitis, BSR,
Screening, Treatment and Management of Lupus Nephritis, ACR,
Fluid Therapy in Critically Ill Adults, Part 2: Resuscitation Volume, ESICM,
Treatment of Systemic Sclerosis, EULAR,
Management of Systemic Sclerosis, BSR,
